- Home
- VALN
VALN
Valneva SE
as 03-25-2025 2:34pm EST
| Founded: | 2012 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | $16.00 | AVG Volume (30 days): | 17.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.62 - $9.50 | Next Earning Date: | 03-20-2025 |
| Revenue: | $175,564,758 | Revenue Growth: | 10.32% |
| Revenue Growth (this year): | 19.17% | Revenue Growth (next year): | 26.31% |
Latest Valneva SE News
VALN Breaking Stock News: Dive into VALN Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
Valneva Files $350 Million Shelf
GlobeNewswire
a day ago
Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F
Pharmaceutical Technology
2 days ago
Valneva outlays 40,000 vaccines to Réunion amidst chikungunya surge
GlobeNewswire
2 days ago
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
GuruFocus.com
5 days ago
Valneva SE (VALN) Q4 2024 Earnings Report Preview: What To Expect
GuruFocus.com
5 days ago
Valneva SE (INRLF) (FY 2024) Earnings Call Highlights: Strong Sales Growth and Strategic ...
GlobeNewswire
6 days ago
Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
Simply Wall St.
16 days ago
High Growth Tech Stocks In Europe For March 2025
Compare VALN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VALN Valneva SE - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.